Benzinga's Top Pre-Market NASDAQ Losers (BMTI, MNKD, HEAT, ATPG)

BioMimetic Therapeutics Inc

dipped 18.67% to $10.89 in the pre-market session. BMTI reported a Q1 net loss of $8.0 million. MannKind Corporation

fell 14.09% to $3.78 in the pre-market session. MNKD reported wider-than-expected Q1 loss. Food and Drug Administration (FDA) told MannKind to run additional trials on its drug Afrezza. SmartHeat Inc

moved down 11.11% to $2.80 in the pre-market session. HEAT reported a 16% y/y decline in its Q1 sales. ATP Oil & Gas Corporation

dropped 5.80% to $15.60 in the pre-market trading. ATPG posted a Q1 net loss of $119.5 million. Read more